Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review

Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review

Chakrapani Balijepalli,1 Lakshmi Gullapalli,1 Eric Druyts,1 Kevin Yan,1 Kamal Desai,1 Stephane Barakat,2 Jason Locklin2 1Pharmalytics Group, Vancouver, British Columbia, Canada; 2Alexion Pharmaceuticals, Vaughan, Ontario, CanadaCorrespondence: Chakrapani Balijepalli Email chak.balijepalli@pharmalyti...

Full description

Bibliographic Details
Main Authors: Balijepalli C, Gullapalli L, Druyts E, Yan K, Desai K, Barakat S, Locklin J
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
orphan drugs
rare diseases
cadth
qaly
hta
Online Access:https://www.dovepress.com/can-standard-health-technology-assessment-approaches-help-guide-the-pr-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/can-standard-health-technology-assessment-approaches-help-guide-the-pr-peer-reviewed-article-CEOR

Similar Items